Project Details
Description
A Phase 1, multicenter, open-label, dose escalation and expansion study to evaluate the safety, tolerability, and pharmacokinetics of MEDI0639 as a single-agent or in combination therapy in adult subject
| Status | Finished |
|---|---|
| Effective start/end date | 3/10/14 → 3/30/19 |
Funding
- MEDIMMUNE, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.